92 related articles for article (PubMed ID: 11712426)
1. Erythropoietin (r-HuEPO) in the treatment of anemia of nodular sclerosis type Hodgkin's disease--a preliminary report.
Wojtukiewicz MZ; Sawicki Z; Radziwon P
Rocz Akad Med Bialymst; 2000; 45():145-9. PubMed ID: 11712426
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
4. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
Pangalis GA; Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kyrtsonis MC; Konstantopoulos K; Tsaftaridis P; Vaiopoulos GA; Kontopidou FN
Haematologica; 2002 May; 87(5):500-6. PubMed ID: 12010663
[TBL] [Abstract][Full Text] [Related]
5. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events.
Rosenzweig MQ; Bender CM; Lucke JP; Yasko JM; Brufsky AM
J Pain Symptom Manage; 2004 Feb; 27(2):185-90. PubMed ID: 15157043
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia].
Gałeza-Obrepalska B; Dwilewicz-Trojaczek J; Paszkowska M; Kuratowska Z
Pol Tyg Lek; 1996 May; 51(19-22):285-8. PubMed ID: 9289712
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
[TBL] [Abstract][Full Text] [Related]
9. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
[TBL] [Abstract][Full Text] [Related]
10. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
11. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
12. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
[TBL] [Abstract][Full Text] [Related]
13. Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes.
Musto P; Falcone A; Sanpaolo G; Bodenizza C
Leuk Res; 2006 Apr; 30(4):385-8. PubMed ID: 16219350
[TBL] [Abstract][Full Text] [Related]
14. Use of erythropoietin in patients with multiple myeloma.
Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
[TBL] [Abstract][Full Text] [Related]
15. [Human recombinant erythropoietin in the treatment of the severe anemia following labor (a preliminary report)].
Malinova M
Akush Ginekol (Sofiia); 1999; 38(4):13-5. PubMed ID: 10726343
[TBL] [Abstract][Full Text] [Related]
16. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus infection, anemia, and survival.
Moore RD
Clin Infect Dis; 1999 Jul; 29(1):44-9. PubMed ID: 10433563
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
San Miguel JF; García-Sanz R
Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
[TBL] [Abstract][Full Text] [Related]
19. Role of erythropoietin in anemia after heart transplantation.
Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
Keast DH; Fraser C
Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
